We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Avenues for Use of Single-Molecule Detection Assays in Clinical Diagnosis

By LabMedica International staff writers
Posted on 03 Oct 2022

Each day, millions of biological processes occur in our body at a cellular level. More...

Studying these processes can help us learn more about how cells function, a field that has continued to intrigue researchers. Recently, however, there has been a new player in this field. A new analytical method - single-molecule detection - has gained momentum due to its success in observing specific, biologically relevant molecules and the processes associated with them. Scientists have tried ways to use single-molecule detection assays to study proteins and their post-translational modifications (PTMs). PTMs are enzymatic changes observed after protein synthesis, wherein functional groups are added to the amino acids in the protein, enabling it to perform a specific function. The study of PTMs can help us understand cell signaling and the origin of several diseases. However, assays aiming to do so have to be highly selective and specific to that protein. Given the lack of sensitivity of current techniques, obtaining single-molecule PTM measurements is challenging. Now, a team of researchers has found an “electrifying” way to overcome these limitations, opening up new avenues for the use of single-molecule detection of PTMs in clinical diagnosis and pharmaceutical applications.

In the recent breakthrough, a team of scientists at the Tokyo Institute of Technology (Tokyo, Japan) reported the single-molecule detection of phosphorylation in peptides - short amino acid chains - and the formation of an orthophosphate junction with the help of electronic signatures. To start with, the team studied the electronic properties of phosphorylated peptides using their inorganic analog, orthophosphoric acid (H3PO4). They prepared a phosphate solution (PO43-­) and subjected it to a scanning tunneling microscope (STM)-assisted break-junction (BJ) technique. When the current was passed between two gold STM electrodes, an orthophosphate group was found to bridge the nanogap between the electrodes by forming a stable junction due to the interaction of its negatively charged oxygen atoms with the gold. It was this junction and its signature that drove further experiments.

The single-orthophosphate junction was found to possess a high conductance of 0.4 G0 and distinct electronic properties, the latter of which enabled this procedure to be highly specific and accurately sense the PTM in question (i.e., phosphorylation). To further test their technique, the team carried out in situ single-molecule phosphorylation assays, where they were able to differentiate between phosphorylated and non-phosphorylated peptides with 95% accuracy and 91% specificity. The method demonstrated in this study provides an unforeseen perspective into the world of PTMs in proteins. This novel technique will also open up new avenues for the use of single-molecule detection of PTMs in clinical diagnosis and pharmaceutical applications.

“There is a strong connection between protein phosphorylation and the pathogenesis of a wide range of diseases” said Associate Professor Tomoaki Nishino from the Tokyo Institute of Technology. “Our method will allow scientists to detangle how phosphorylation regulates the cellular events that lead to the origin of a disease and thereby aid in the development of treatments.”

Related Links:
Tokyo Institute of Technology 


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Collection and Transport System
PurSafe Plus®
New
Gold Member
Hybrid Pipette
SWITCH
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.